No CrossRef data available.
Article contents
Evaluation of computerized clinical decision support system to reduce unnecessary nasal methicillin-resistant Staphylococcus aureus (MRSA) polymerase chain reaction (PCR) testing
Published online by Cambridge University Press: 12 December 2023
Abstract
Our health system implemented a novel clinical decision-support system to reduce unnecessary duplicate nasal methicillin-resistant Staphylococcus aureus (MRSA) polymerase chain reaction (PCR) orders. In an 8-month period, the rate of duplicate MRSA PCR orders within 7 days declined from 4.7% (370 of 7,861) to 1.2% (120 of 9,833).
- Type
- Concise Communication
- Information
- Copyright
- © The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
References
Fabre, V, Davis, A, Diekema, DJ, et al. Principles of diagnostic stewardship: a practical guide from the Society for Healthcare Epidemiology of America Diagnostic Stewardship Task Force. Infect Control Hosp Epidemiol 2023;44:178–185.CrossRefGoogle Scholar
Curren, EJ, Lutgring, JD, Kabbani, S, et al. Advancing diagnostic stewardship for healthcare-associated infections, antibiotic resistance, and sepsis. Clin Infect Dis 2022;74:723–728.CrossRefGoogle ScholarPubMed
Turner, SC, Seligson, ND, Parag, B, Shea, KM, Hobbs, ALV. Evaluation of the timing of MRSA PCR nasal screening: how long can a negative assay be used to rule out MRSA-positive respiratory cultures? Am J Health Syst Pharm 2021;78 suppl 2:S57–S61.CrossRefGoogle Scholar
Paule, SM, Mehta, M, Hacek, DM, Gonzalzles, TM, Robicsek, A, Peterson, LR. Chromogenic media vs real-time PCR for nasal surveillance of methicillin-resistant Staphylococcus aureus: impact on detection of MRSA-positive persons. Am J Clin Pathol 2009;131:532–539.CrossRefGoogle ScholarPubMed